Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of a health claim related to an equimolar mixture of the CLA isomers c 9, t 11 and t 10, c 12 (marketed as Clarinol® and Tonalin®) and “contributes to a reduction in body fat mass” pursuant to Article 13(5) of Regulation (EC) No 1924/2006 | Zendy

AI Assistant Blog Pricing

Open Access

Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of a health claim related to an equimolar mixture of the CLA isomers c 9, t 11 and t 10, c 12 (marketed as Clarinol® and Tonalin®) and “contributes to a reduction in body fat mass” pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Publication year - 2015

Publication title -

efsa supporting publications

Language(s) - English

Resource type - Journals

ISSN - 2397-8325

DOI - 10.2903/sp.efsa.2015.en-858

Subject(s) - food safety , health claims on food labels , environmental health , european commission , food science , political science , business , european union , medicine , chemistry , economic policy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.